Antibiotic management of patients with suspected COVID-19 admitted from the community – ICST

Antibiotic management of patients with suspected COVID-19 admitted from the community

Developed by the Respiratory Health Implementation Group, the Antibiotic management of patients with suspected COVID-19 admitted from the community provides a structured approach to determine whether the patient with suspected COVID-19 has a superadded bacterial infection or community acquired pneumonia. Key recommendations:
  • Using chest x-ray and blood tests to determine the likelihood of COVID-19, COVID-19 with superadded (aka secondary) bacterial infection, or community acquired pneumonia (CAP)
  • Risk stratify patients for sepsis using the CURB-65 score, and treated with antibiotics accordingly
  • Ongoing antibiotic management determined by the result of the COVID-19 result

© Institute of Clinical Science and Technology (ICST) 2020

Support: admin@clinicalscience.org.uk